 Vancouver, Bristish Columbia and Minneapolis, Minnesota--Newsfile Corp. - January 19, 2021 - Neovasc Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company announced today that the Neovasc ReducerTM Reducer was prominently featured in three peer reviewed European Journals. Management of refractory angina: an update1 was published in the European Heart Journal. This leading publication came to the conclusion, At present, accumulating evidence supports the clinical benefit of the Reducer in alleviating symptoms... 